Enterobacter cloacae

{{Short description|Species of bacterium}}

{{Use dmy dates|date=April 2017}}

{{Citation style|date=October 2021}}

{{Speciesbox

| image = Enterobacter_cloacae_01.png

| image_caption = Enterobacter cloacae on tryptic soy agar

| genus = Enterobacter

| species = cloacae

| authority = (Jordan 1890)
Hormaeche and Edwards 1960

| subdivision_ranks = Subspecies

| subdivision =

Aerobacter cloacae (Jordan 1890) Hormaeche and Edwards 1958
Erwinia dissolvens (Rosen 1922) Burkholder 1948
Pseudomonas dissolvens Rosen 1922
Bacterium dissolvens Rosen 1922
Phytomonas dissolvens (Rosen 1922) Rosen 1926
Aplanobacter dissolvens (Rosen 1922) Rosen 1926
Aerobacter dissolvens (Rosen 1922) Waldee 1945
Enterobacter dissolvens (Rosen 1922) Brenner et al. 1988

}}

Enterobacter cloacae is a clinically significant Gram-negative, facultatively-anaerobic, rod-shaped bacterium.

Microbiology

In microbiology laboratories, E. cloacae is frequently grown at 30 °C on nutrient agar or at 35 °C in tryptic soy broth.{{cite journal|vauthors=Dalben M, Varkulja G, Basso M, Krebs VL, Gibelli MA, van der Heijden I, Rossi F, Duboc G, Levin AS, Costa SF |title=Investigation of an outbreak of Enterobacter cloacae in a neonatal unit and review of the literature.|journal=The Journal of Hospital Infection|date=September 2008|volume=70|issue=1|pages=7–14|pmid=18632183|doi=10.1016/j.jhin.2008.05.003}} It is a rod-shaped, Gram-negative bacterium, is facultatively anaerobic, and bears peritrichous flagella. It is oxidase-negative and catalase-positive.{{cite web|url=https://microbiologyinfo.com/biochemical-test-and-identification-of-enterobacter-cloacae/ |title=Biochemical Test and Identification of Enterobacter cloacae |publisher=microbiologyinfo |access-date=2017-07-26|date=2017-05-24 }}

Industrial use

Enterobacter cloacae has been used in a bioreactor-based method for the biodegradation of explosives and in the biological control of plant diseases.{{cite journal |vauthors=Pudge IB, Daugulis AJ, Dubois C|title=The use of Enterobacter cloacae ATCC 43560 in the development of a two-phase partitioning bioreactor for the destruction of hexahydro-1,3,5-trinitro-1,3,5-s-triazine (RDX) |journal=Journal of Biotechnology |volume=100 |issue=1 |pages=65–75 |date=2003 |pmid=12413787 |doi=10.1016/s0168-1656(02)00229-8}} Enterobacter cloacae strain MBB8 isolated from the Gulf of Mannar, India was reported to degrade poly vinyl alcohol (PVA). This was the first report of a PVA degrader from the Enterobacter genus.{{cite journal|vauthors= Prakash Shyam K, Rajkumar P, Ramya V, and Mohisha Miriam LR |title=Biorefining Polyvinyl Alcohol (PVA) by Enterobacter cloacae and its Polyhydroxy Butyrate (PHB) Production Ability.|journal=Industrial Biotechnology|date=2021|volume=17|issue=2|pages=92–99|doi=10.1089/ind.2020.0039|s2cid=235579922 }} E. cloacae was also reported to produce exopolysaccharide (EPS) as high as 18.3g/L.{{cite journal|vauthors= Prakash Shyam K, Rajkumar P, Ramya V, Sivabalan S, Kings JA, and Mohisha Miriam LR |title= Exopolysaccharide production by optimized medium using novel marine Enterobacter cloacae MBB8 isolate and its antioxidant potential.|journal= Carbohydrate Polymer Technologies and Applications|date=2021|volume=2| pages= 100070|doi= 10.1016/j.carpta.2021.100070|doi-access= free}} GC-MS analysis of E. cloacae EPS showed the presence of glucose and mannose in the molar ratio of 1: 1.5e−2.

Enterobacter cloacae subsp. cloacae strain PR-4 was isolated and identified by 16S rDNA gene sequence with phylogenetic tree view from explosive-laden soil by P. Ravikumar (GenBank accession number KP261383).Ravikumar. P. GenBank New holotype for Enterobacter cloacae subsp. cloacae strain PR-4 isolated and identified by 16S rDNA gene sequence with Phylogenetic tree view, from explosive laden soil. Int J.of Res in Engineering and Science, (6) 5:53-65 2016.

E. cloacae SG208 identified as a predominant microorganism in mixed culture isolated from petrochemical sludge (IOCL, Guwahati) responsible for degradation of benzene was reported by Padhi and Gokhale (2016).Padhi, S.K., Gokhale, S., 2016. Benzene biodegradation by indigenous mixed microbial culture: Kinetic modeling and process optimization. International Biodeterioration & Biodegradation. {{doi|10.1016/j.ibiod.2016.10.011}}

Safety

Enterobacter cloacae is considered a biosafety level 1 organism in the United States and level 2 in Canada.{{citation needed|date=December 2012}}

Genomics

A draft genome sequence of Enterobacter cloacae subsp. cloacae was announced in 2012. The bacteria used in the study were isolated from giant panda feces.{{cite journal|last=Yan|first=Y|author2=Zhao, CW |author3=Zhang, YZ |author4=Zhang, ZH |author5=Pan, GL |author6=Liu, WW |author7=Ma, QY |author8=Hou, R |author9= Tan, XM |title=Draft Genome Sequence of Enterobacter cloacae subsp. cloacae Strain 08XA1, a Fecal Bacterium of Giant Pandas.|journal=Journal of Bacteriology|date=December 2012|volume=194|issue=24|pages=6928–9|doi=10.1128/JB.01790-12|pmid=23209197|pmc=3510591}}

Clinical significance

Enterobacter cloacae is a member of the normal gut flora of many humans and is not usually a primary pathogen.{{cite journal|last=Keller|first=R|author2=Pedroso, MZ |author3=Ritchmann, R |author4= Silva, RM |title=Occurrence of virulence-associated properties in Enterobacter cloacae.|journal=Infection and Immunity|date=February 1998|volume=66|issue=2|pages=645–9|doi=10.1128/IAI.66.2.645-649.1998|pmid=9453621|pmc=113501}} Some strains have been associated with urinary tract and respiratory tract infections in immunocompromised individuals. It is a high risk AmpC producer and treatment with cefepime is recommended by the IDSA if causing disease rather than simply colonising.{{cite news | url=https://www.idsociety.org/practice-guideline/amr-guidance/#AmpC%CE%B2-Lactamase-ProducingEnterobacterales | title=AMR Guidance }} Treatment using cefepime and gentamicin has been reported.{{cite journal |vauthors=Barnes BJ, Wiederhold NP, Micek ST, Polish LB, Ritchie DJ |title=Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature |journal=Pharmacotherapy |volume=23 |issue=4 |pages=537–42 |date=April 2003 |pmid=12680484 |doi= 10.1592/phco.23.4.537.32126|s2cid=22547516 }}

A 2012 study in which Enterobacter cloacae was transplanted into previously germ-free mice resulted in increased obesity when compared with germ-free mice fed an identical diet, suggesting a link between obesity and the presence of Enterobacter gut flora.{{Cite journal|title=An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice|journal=The ISME Journal|volume=7|issue=4|pages=880–884|author=Na Fei|author2=Liping Zhao|date=13 December 2012|doi=10.1038/ismej.2012.153|pmid=23235292|pmc=3603399}}

See also

References

{{Reflist}}